Next Article in Journal
Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance
Next Article in Special Issue
Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
Previous Article in Journal
Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma
Previous Article in Special Issue
Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study
 
 
Review
Peer-Review Record

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer

Cancers 2021, 13(8), 1791; https://doi.org/10.3390/cancers13081791
by Francesco Cuccia 1, Stefanie Corradini 2, Rosario Mazzola 1, Luigi Spiazzi 3,*, Michele Rigo 1, Marco Lorenzo Bonù 4,5, Ruggero Ruggieri 1, Michela Buglione di Monale e Bastia 4,5, Stefano Maria Magrini 4,5 and Filippo Alongi 1,5
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Cancers 2021, 13(8), 1791; https://doi.org/10.3390/cancers13081791
Submission received: 4 March 2021 / Revised: 1 April 2021 / Accepted: 2 April 2021 / Published: 9 April 2021
(This article belongs to the Special Issue Prostate Cancer Radiotherapy: Recent Advances and Challenges)

Round 1

Reviewer 1 Report

  1. Page 1 abstract: the authors should distinguish b/w MR-guided RT using offline MRs (MRI fused with planning CTs and delivered using standard LINACs) and combined MR-LINAC machines
  2. Page 2, para 2.  The "hybrid machines" - there are no machines referred before (unless referring to MR-guided RT being a MR-LINAC).  See comment #1
  3. Pg 2, para 6: aren't these machines a lot more expensive?  why then would there be positive socio-economic implications
  4. Pg 2, para 7: please detail your systematic review methods and findings
  5. Pg 3, para 3: spacers are more to push the rectum out of the high dose region not to reduce prostate motion (the refs provided don't talk about margin reduction)
  6. Pg 3, para 4: "prostate fixation" would require the spacer to "push" against the rectum but rectum is air filled most of the time and compliant.  Doesn't make sense from a physics point of view
  7. Pg 6, para 2: please provide refs for large prostate size and TURP being contraindications for SBRT

 

Author Response

please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

General comments

This is well written review on a timely subject. MR-linacs are installed in the radiation oncology departments around the world. Still there is a lot of evidence lacking about the clinical benefits of the technique. This review focus on hypofractionation radiotherapy of localized prostate cancer. The current available clinical evidence is summarized. This will give a very useful scientific update as well as creating a road map for the future work to be done. The section “Present evidence” is rather short followed of “Future directions”, which has several relevant subsections of interest. There is one issue with the manuscript, which easily can be improved. It is sometimes hard to realize if the studies the authors refer to relates to MR-guided RT using MR-linac or general IGRT with/or without MR-scanner. Please be specific on this matter and state whether the studies referred to are using MR-linac.

It would be valuable if the authors can make table of the studies using MR-linac, which creates the present evidence for radiotherapy of prostate cancer.

 

Specific comments

page 2 “MR-guided radiotherapy”

There is a description of adapt-to-position/adapt to shape (ADP/ATS). On page 3 ADP/ATS is explained again. It would be sufficient to introduce these methods once.

 

page 3

The pulse sequences are not described in a similar manner for Elekta and Viewray. T2-weighted sequence is a description of the contrast not a specific sequence. However, TRUFI is a method based on the pulse sequence truefisp (or bSSFP) and not a description of the contrast. It stands for True Fast Imaging with Steady State Precession. Please, rewrite this paragraph using a correct “MRI language”.

 

Patient selection

This paragraph address “physical limitations”. Considering the size of the bore in MR-linacs, it would make sense to elaborate on patient weight and body mass index with respect to patient selection. Men with cancer prostate are often at an age, in which obesity is frequent. Additionally, the size of the treatment field can be quite restricted in the superior/inferior direction. This is a limitation which may affect cancer prostate treatments which include the seminal vesicles.

Author Response

please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

In this submitted manuscript, the authors summarized currently available MR-guided hypofractionated radiotherapy data for treatment of localized prostate cancer. These compared MR-guided RT and SBRT with different treatment protocols. The field actually needs such retroperspective studies and perspective outlook. However I found this review is not comprehensive enough to serve as a guidance and provide sufficient insight to the field. I recommend reconsideration after the authors can address the following issues.

Reviews normally include figures and tables that clearly demonstrate the principle of these techniques, pros and cons of the technologies, different treatments etc. However this manuscript provides no one illustration for the purpose of simple readership.

 

Author Response

please see the attachment

Author Response File: Author Response.docx

Round 2

Reviewer 3 Report

The current manuscript is publishable.

Back to TopTop